Zhihao Lu

Peking University - Key Laboratory of Carcinogenesis and Translational Research

Beijing, 100142

China

SCHOLARLY PAPERS

2

DOWNLOADS

49

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Safety, Efficacy and Biomarkers of Toripalimab in Patients with Recurrent or Metastatic Neuroendocrine Neoplasms: A Multiple-Center Phase Ib Trial

Number of pages: 139 Posted: 26 Nov 2019
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Harbin Medical University - Cancer Hospital, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, OrigiMed, Inc., Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD and Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
Downloads 32 (618,371)

Abstract:

Loading...

Neuroendocrine neoplasm, NET, NEC, PD-1,toripalimab

2.

Early Interdisciplinary Palliative Care in Patients with Previously Untreated Metastatic Oesophagogastric Cancer: A Phase 3 Randomised Controlled Trial

Number of pages: 68 Posted: 07 Aug 2020
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Clinical Nutrition, Peking University - Department of Gastrointestinal Oncology, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Clinical Nutrition, Peking University - Department of Psycho-Oncology, Peking University - Department of Gastrointestinal Oncology, Peking University - Department of Gastrointestinal Oncology, Precision Scientific (Beijing) Co., Ltd., Peking University - Department of Psycho-Oncology, Peking University - Department of Clinical Nutrition, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Gastrointestinal Oncology, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Department of Psycho-Oncology and Peking University - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)
Downloads 17 (727,737)

Abstract:

Loading...

Early interdisciplinary palliative care; oesophagogastric cancer; survival; randomised controlled trial